Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens

Clinical Infectious Diseases

Volumn 31, Issue 1, 2000, Pages 162-166

  Lonergan, J Tyler ^a   Behling, Cynthia ^a   Pfander, Hans ^a   Hassanein, Tarek I ^a   Mathews, W Christopher ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; DRUG EFFECT; ENZYME INHIBITION; FATTY LIVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; LACTIC ACIDOSIS; LIVER DISEASE; MALE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY;

ACIDOSIS, LACTIC; ADULT; ALANINE TRANSAMINASE; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; NUCLEOSIDES; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0034456472     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313912     Document Type: Article

References (28)

1. A new syndrome of hepatomegaly with severe steatosis in HIV-seropositive patients
2. Mitochondrial toxicity of antiviral nucleoside analogs
3. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
4. Fulminant hepatic failure associated with 2′,3′-dideoxyinosine (ddI)
5. Hepatomegaly with severe steatosis in HIV-seropositive patients
6. Fulminant hepatitis with severe lactic acidosis in HIV-infected patients on didanosine therapy
7. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine
8. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy
9. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: A case report
10. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature
11. Riboflavin to treat nucleoside analogue-induced lactic acidosis
12. Fatal lactic acidosis following HAART containing stavudine (d4T), lamuvidine (3TC) and saquinavir
13. The 'steatosis-lactic acidosis syndrome' (SLAS) in early stage HIV infection treated with HAART [abstract 60611]
14. Concurrent zidovudine-induced myopathy and hepatotoxicity in patients treated for human immunodeficiency virus (HIV) infection
15. Zidovudine-induced hepatitis
16. Lactic acidosis complicating the acquired immunodeficiency syndrome
17. Lactic acidosis and AIDS
18. Type B lactic acidosis in an AIDS patient treated with zidovudine
19. Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine
20. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion
21. Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient
22. Lactic acidosis
23. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter
24. Delta: A randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
25. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity
26. Favorable interaction of β-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus
27. Lack of mitochondrial toxicity in CEM cells treated with carbovir
28. A syndrome of lipodystrophy (LD), lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue reverse transcriptase inhibitor therapy: Contribution to PI-related LD syndrome